Medistep Healthcare IPO listed at a 23.26% premium on NSE at ₹53

Medistep Healthcare IPO listing gain is 23.26% on NSE, the stock opened at ₹53. The IPO GMP was ₹8 last heard.

Table of Contents

Medistep Healthcare IPO was subscribed 382.14 times on the last day, a retail quota was subscribed over 461.11 times, NII subscribed over 289.15 times, and QIB was 0.00 times, respectively.   

Details About Medistep Healthcare IPO 

Medistep Healthcare IPO received approval from SEBI for an IPO worth ₹16.10 crores. Wherein a fresh issue would be totally ₹16.10 crores. 

Further, Medistep Healthcare IPO had a set price band of ₹43 Per Share. 

Medistep Healthcare IPO consists of 6,000 shares in 2 lot size for retail minimum and maximum categories as well. While 9,000 shares were in 3 lot sizes for the S-HNI category. 

To invest in the Medistep Healthcare IPO, each investor category has specific investment amounts: 

  • Retail Investors: Minimum and maximum investment of ₹2,58,000.   
  • SHNI (S-HNI): Minimum investment of ₹3,87,000. 

Medistep Healthcare IPO Subscription Duration 

Medistep Healthcare IPO opened on August 8, 2025, and closed on August 12, 2025. The Medistep Healthcare IPO allotment date was scheduled on August 13, 2025. The Medistep Healthcare IPO listing date is on August 18, 2025.  

Medistep Healthcare IPO funds deployment 

  • Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility
  • Working Capital requirements
  • General Corporate Purpose

About Medistep Healthcare IPO Company 

Medistep Healthcare Limited is a leading pharmaceutical company that deals in a wide range of products including medicines, hygiene and intimate care items, surgical products, and health supplements. The company was established on June 5, 2023. It is also known for providing high-quality sanitary pads to support feminine hygiene. To expand its business, Medistep acquired M/s MG Pharma, a firm previously owned by one of its promoters, Ms. Prajapati Hetalben Girdharilal. The company follows key strategies such as market analysis, product development, strict quality standards, and a strong sales and distribution network. Its major strengths include a skilled management team, a variety of healthcare products, and the manufacturing of well-known items like DRYSTEP sanitary pads and VITASTEP Z energy powders.

Financial Report of the Medistep Healthcare IPO Company

The company earned ₹49.66 crores in revenue in 2025, up from ₹39.08 crores in 2024. Its profit also increased to ₹4.14 crores in 2025, compared to ₹3.33 crores in 2024.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.